Enzymotec breakthrough to improve fatty acid delivery

- Last updated on GMT

Related tags: Fatty acid, Nutrition

Israeli biotech firm Enzymotec has developed an enzyme technology
that it claims will improve targeted delivery of nutrients in oils
to human organs.

The patented technology, developed during three years of research with Professor Yuval Shoham at the Technion Institute in Israel, is based on the enzyme lipase, which breaks down lipids, including triglycerides, for their absorption and digestion.

Professor Shoham, head of food engineering and biotechnology at the Technion Institute, says the new technology, dubbed 'Lipase 2', can reach the fatty acid that is located on the second position (Sn-2) of the triglyceride, or the one used by our bodies, giving food manufacturers greater control over the nutritional or therapeutic benefits offered by the nutrient.

"All other known lipases can build or break down only the first and third positions while the human metabolism uses the bounded second position as a building block for other essential elements,"​ he explained.

Avidor Shulman, Enzymotec's director of innovation, added: "Fats and oils are found all over our body and are the most natural delivery system we have. But in order to deliver the right fatty acid to the right organ, they have to be in a specific position. Until now, there has been no elegant way to predetermine this position."

The company, which develops innovative lipid-based ingredients for the nutraceuticals and functional food markets, plans to use the enzyme to develop new products although it has not ruled out external licensing agreements.

For instance, it could enhance absorption of omega-3 fatty acids by specific organs such as the brain. It could also improve delivery of fat-soluble vitamins or even other active ingredients, according to Shulman.

"At a later stage you could even use it for pharmaceutical actives or to create oils and fats with a different viscosity or other properties,"​ he added.

However the primary focus for Enzymotec will be to deliver superior nutritional benefits from fat- or oil-based foods or supplements. It is currently running clinical trials to test the improved nutrient delivery.

In recent years other researchers had tried to identify Sn-2-specific enzymes but none are thought to have found one with such selective activity.

Related news

Show more

Related products

Attract a new generation of omega-3 consumers

Attract a new generation of omega-3 consumers

DSM Nutritional Products | 15-Sep-2022 | Infographic

Want to bring your next omega-3 innovation to market quickly and sustainably? DSM's algal-sourced life's™OMEGA, enables you to get consumer-driven,...

DurOmega® Algal DHA 20% water dispersible powder

DurOmega® Algal DHA 20% water dispersible powder

INNOBIO Corporation Limited | 30-May-2022 | Technical / White Paper

INNOBIO most recently launched a new product DurOmega® Algal DHA 20% water dispersible powder with significantly reduced fishy odor and taste, which optimizes...



POLARIS | 02-Feb-2022 | Data Sheet

Polaris introduces its first 100% vegan powder, highly concentrated in DHA, with neutral taste and smell. Perfect for tableting, powder drinks and many...

Related suppliers

Follow us


View more